REACTINE 5 MG / 5 ML
CETIRIZINE HYDROCHLORIDE : 5 MG / 5 ML · DIN 02238337 · MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
Health Canada status: MARKETED
What is REACTINE?
REACTINE 5 MG / 5 ML contains CETIRIZINE HYDROCHLORIDE : 5 MG / 5 ML. It is listed in the Health Canada Drug Product Database under DIN 02238337, held by MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC, supplied as SYRUP for ORAL administration. Health Canada currently lists it as marketed, status dated 12-Mar-2026. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is REACTINE used for?
REACTINE® (cetirizine hydrochloride) is indicated for the fast relief of nasal and non-nasal symptoms associated with seasonal and perennial allergic rhinitis (i.e. sneezing, rhinorrhea, post-nasal discharge, nasal congestion/stuffiness, tearing and redness of the eyes, itchy nose/throat) and chronic idiopathic urticaria (e.g. pruritus and hives) in adults and children 12 years of age and over. In pediatrics (children 2-12 years of age), REACTINE® is indicated for the relief of symptoms associated with seasonal allergic rhinitis and for the fast and long-lasting relief of itching due to allergic skin reactions such as hives.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02238337 |
|---|---|
| Brand name | REACTINE |
| Generic / active ingredient | CETIRIZINE HYDROCHLORIDE : 5 MG / 5 ML |
| Manufacturer | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC |
| Strength | 5 MG / 5 ML |
| Dosage form | SYRUP |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R06AE07 CETIRIZINE |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 12-Mar-2026 |
How is it stored and handled?
null
How is it supplied?
REACTINE® 5 mg tablets are supplied in blister packs of 36 tablets. REACTINE® 10 mg tablets are supplied in blister packs of 3, 10, 20, 30, 48 and 84 tablets, and in bottles of 120 and 175 tablets. REACTINE® FAST MELT® Junior are supplied in blister packages of 12 and 24 tablets. REACTINE® Rapid Dissolve are supplied in blister packages of 24 and 48 tablets. REACTINE® Allergy Liquid Gels are available in bottles of 25 and 40. REACTINE® and REACTINE® Allergy syrup is supplied in 118 mL plastic bottles. A sample size of REACTINE® syrup is supplied in 30 mL plastic bottles.
What can be used instead?
Other Canadian products sharing ATC code R06AE07 CETIRIZINE. 27 of 65 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ALLERGY RELIEF | 10 MG | TABLET | APOTEX INC | MARKETED | DIN 02240266 |
| ALLERGY RELIEF LIQUID GELS | 10 MG | CAPSULE | JUNO OTC INC | MARKETED | DIN 02528738 |
| APO-CETIRIZINE | 10 MG | TABLET | APOTEX INC | MARKETED | DIN 02231603 |
| APO-CETIRIZINE | 20 MG | TABLET | APOTEX INC | MARKETED | DIN 02453363 |
| BIO-CETIRIZINE | 20 MG | TABLET | BIOMED PHARMA | MARKETED | DIN 02510030 |
| CETIRIZINE | 20 MG | TABLET | SANIS HEALTH INC | MARKETED | DIN 02515695 |
| CETIRIZINE | 20 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02534126 |
| EXTRA STRENGTH ALLERGY RELIEF | 10 MG | TABLET | PHARMASCIENCE INC | MARKETED | DIN 02315955 |
| EXTRA STRENGTH ALLERGY RELIEF | 10 MG | TABLET | VITA HEALTH PRODUCTS INC | MARKETED | DIN 02540495 |
| JAMP-CETIRIZINE | 10 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02451778 |
Who else supplies CETIRIZINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. CETIRIZINE appears in 177 registered pack listings across 9 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.